The HSE National Office for Suicide Prevention (NOSP) was established to strategically lead on suicide prevention efforts across the HSE and in collaboration with multiple partners. This work is underpinned by Connecting for Life, Ireland’s National Strategy to Reduce Suicide. The HSE NOSP sits within Access and Integration in the HSE. The core work streams within the HSE NOSP encompass strategy coordination, education and training, NGO support, local implementation support, suicide bereavement, monitoring and evaluation, communications and clinical advisory.

PDF p.24 Preventing Paracetamol-Related Drug Overdose The Preventing Paracetamol-Related Drug Overdose Working Group was established in 2021 and is led by the Department of Health (Chair), the HSE NOSP, and National Suicide Research Foundation – with membership including the Irish Pharmacy Union, Pharmaceutical Society of Ireland and the Health Products Regulatory Authority. The group was established to develop a programme of work to prevent intentional paracetamol overdose in Ireland. Work of the Group in 2024 included the ongoing dissemination of campaign material, aimed at raising awareness of paracetamol sales restrictions across pharmacy and non-pharmacy retail settings. In order to inform practical next steps for the Group, work was completed to design and conduct a national survey examining retail and pharmacy staff’s knowledge of paracetamol sales legislation, perceptions of training and materials, experiences of limiting pack sales and approaches to enhancing adherence. The survey findings were presented by the NSRF, at the PRIMM Prescribing and Research in Medicines Management Conference in Manchester in May 2024. Further, preparations were completed to design and conduct an additional national mystery-shopping-type surveillance exercise (in early 2025), to measure adherence across pharmacy and non-pharmacy retail settings.